| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/03/2008 | EP1963263A1 POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)- BETA,DELTA -DIHYDROXY-5-(L-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1) |
| 09/03/2008 | EP1962882A1 Compositions and methods for treatment of diabetes |
| 09/03/2008 | EP1962859A1 Vitamin d derivatives for the treatment of type i diabetes |
| 09/03/2008 | EP1962858A1 Phytosterols for use in reducing c-reactive protein levels |
| 09/03/2008 | EP1962840A1 Use of 4, 7-dihydrothieno [2, 3-b]pyridine compounds in the treatment of cardiovascular diseases |
| 09/03/2008 | EP1962838A2 Farnesoid x receptor agonists |
| 09/03/2008 | EP1962835A2 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or h3 receptor antagonist/inverse agonist |
| 09/03/2008 | EP1962832A2 Combinations of a qualene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 09/03/2008 | EP1962827A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 09/03/2008 | EP1962826A2 Method for weight reduction |
| 09/03/2008 | EP1604659B1 Tablet containing water-absorbing amino acid |
| 09/03/2008 | EP1496757B1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 09/03/2008 | EP1494680B1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1334720B1 Nateglinide-containing preparations |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 09/03/2008 | EP1257541B1 Polypharmacophoric agents |
| 09/03/2008 | EP1131070B1 Pharmaceutical composition for modified release of an insulin sensitiser and metformin |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/03/2008 | EP1042293B9 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 09/03/2008 | CN101258150A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 09/03/2008 | CN101258137A Dicycloalkyl urea glucokinase activators |
| 09/03/2008 | CN101258136A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer s desease, cognitive disorders, co |
| 09/03/2008 | CN101258131A 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 09/03/2008 | CN101257914A Composition for amelioration of body lipid |
| 09/03/2008 | CN101257910A Cholesterol absorption inhibitor |
| 09/03/2008 | CN101257900A Gsk-3 inhibitors |
| 09/03/2008 | CN101257897A Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 09/03/2008 | CN101257896A Growth promoting agent and life prolonging agent |
| 09/03/2008 | CN101255420A Method for preparation of transgenic rice preparation and use thereof |
| 09/03/2008 | CN101255199A Method for extracting Siberian solomonseal rhizome polysaccharide from siberian solomonseal rhizome |
| 09/03/2008 | CN101255191A Micro-wave promoted solid-phase synthesis of glucagons-like peptide-1(GLP-1) analogue and uses thereof |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2008 | CN101255116A Novel unsaturated fatty acid derivatives as well as preparation method and medicament uses thereof |
| 09/03/2008 | CN101254300A Intestinotrophic glucagon-like peptide-2 analogs |
| 09/03/2008 | CN101254299A Therapy of diabetic under bark dysfunction |
| 09/03/2008 | CN101254293A Medicament combination for clearing stomach, removing heat, spleen-invigorating, spleen-invigorating and relieving liver relieving stagnation and method of preparing the same |
| 09/03/2008 | CN101254271A Gene therapy radically treating diabetes |
| 09/03/2008 | CN101254256A Clearing blood nourishing heart powder |
| 09/03/2008 | CN101254242A Applications of Chinese medicinal composition for preparing inhibition angiotensin II receptor |
| 09/03/2008 | CN101254238A Method for extracting alpha-glucosidase restraining agent effective ingredient from plants |
| 09/03/2008 | CN101254228A Preparation of Yin-nourishing and Yang-strengthening arctium lappa element |
| 09/03/2008 | CN101254207A Iron supplementary liposome iron and method of preparing the same |
| 09/03/2008 | CN101254200A Use of cyclocarya paliurus glycoside compounds for preparing medicament for curing diabetes |
| 09/03/2008 | CN101254190A Compound maleic acid rosiglitazone diabetosan controllable releasing microballoons, method for preparing same and use |
| 09/03/2008 | CN101254187A Combination for curing metabolism syndrome |
| 09/03/2008 | CN101254178A Gliclazide controlled release tablets |
| 09/03/2008 | CN101254168A Composite high-energy nutrient fluid for dog, grimalkin and fox and method of preparing the same |
| 09/03/2008 | CN101253995A Nutrition boiled pork |
| 09/03/2008 | CN101253984A Royal jelly ginkgo leaf nutrition health products and method of preparing the same |
| 09/03/2008 | CN101253903A Health food and its preparation with fat-reducing function |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 09/03/2008 | CN100415741C Thiazolidinedione derivative and its use as antidiabetic |
| 09/03/2008 | CN100415727C Chirale oxazole-arylpropionic acid derivatives and their use as PPAR agonists |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415723C Benzimidazole derivative |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415297C Preparation method of zinc supplements based on cation exchange resin |
| 09/03/2008 | CN100415270C Diabetes treating medicine |
| 09/03/2008 | CN100415260C Application of H. seniavinii Maxim. in preparation of fat-reducing medicine |
| 09/03/2008 | CN100415235C Medicinal composition containing an HMG-CoA reductase inhibitor |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/03/2008 | CN100415226C Electrolyte replenisher for treating hypopotassaemia hypomagnesemia and its uses |
| 09/03/2008 | CN100415224C Compositions comprising fatty acids and amino acids |
| 09/03/2008 | CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 09/03/2008 | CN100415221C Curcumin lyophilized liposome for injection and its preparing method |
| 09/03/2008 | CN100415220C Method of stabilizing reduced coenzyme Q10 |
| 09/03/2008 | CN100415218C Therapeutic agent |
| 09/03/2008 | CN100415215C Wild camellia seed oil soft capsule |
| 09/03/2008 | CN100415210C Peptide/lipid complex formation by co-lyophilization |
| 09/02/2008 | US7420085 Form II; used for facilitating the delivery of active agents, such as insulin, to a target |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 09/02/2008 | US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/02/2008 | US7419956 Isolated physiologically active peptide and use thereof |
| 09/02/2008 | US7419952 Use of exendins and agonists thereof to treat diabetes |
| 09/02/2008 | US7419950 Methods of inhibiting ectopic calcification |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | CA2461757C Nicotine formulations comprising chocolate and use thereof |
| 09/02/2008 | CA2461517C Nicotine formulations comprising cocoa and use thereof |
| 09/02/2008 | CA2381091C Fat composition |
| 09/02/2008 | CA2356158C Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 09/02/2008 | CA2350609C N-substituted 2-cyanopyrrolidines |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 09/02/2008 | CA2144307C Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 08/28/2008 | WO2008103501A1 Compounds and methods for modulating g protein-coupled receptors |
| 08/28/2008 | WO2008103500A1 Thiazole derivatives as modulators of g protein-coupled receptors |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102467A1 External preparation for skin |
| 08/28/2008 | WO2008101943A1 Pharmaceutical metformin hydrochloride formulation and tablet comprising said formulation |
| 08/28/2008 | WO2008101924A1 Semi-fluid food product comprising beta-glucan fibres |
| 08/28/2008 | WO2008101907A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 08/28/2008 | WO2008101886A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 08/28/2008 | WO2008101885A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 08/28/2008 | WO2008101586A1 Benzimidazole derivatives |